OpenAI plans to acquire Pierre Computer, which runs a cloud service where AI agents store the code they generate and builds open-source libraries already used in OpenAI's Codex. Terms were not disclosed.
Agilent Technologies has completed its acquisition of Proscia, a provider of digital-pathology software for clinical and life-sciences customers. Agilent paid $240 million in cash at closing, with up to $30 million more tied to future performance milestones.
KeyCorp, a Cleveland bank with $193 billion in assets, will acquire New York-based Atlantic-Pacific Capital, which has handled about 180 capital-raising assignments totaling $123 billion for alternative asset managers. The deal adds about 30 employees. Terms were not disclosed.
Shareholders of materials engineering company Luxfer Holdings voted at two meetings in London to approve its acquisition by affiliates of Wynnchurch Capital. Under the deal, shareholders will receive $17.37 per share.
Subprime lender OppFi has withdrawn its applications to acquire Arizona-based BNC National Bank, citing a lack of clearly stated standards from the OCC, Fed and FDIC. Its CEO says the merger agreement with BNCCORP remains in effect.
Montreal's AVENIR GLOBAL acquired Marker Collective, owner of the Archetype, Nectar and Outcast agencies and the Delve AI platform, from Next 15 Group.
FIBRA Monterrey completed its internalization of FIBRA Macquarie after a successful tender offer, ending Macquarie Asset Management's management of the vehicle.
SPAC Armada Acquisition Corp. III signed a definitive business combination agreement with Brains Bioceutical, a pharmaceutical ingredient maker and drug developer.
Horizon Quantum signed a non-binding letter of intent to acquire Singapore quantum error-correction firm Entropica Labs for about $27 million in shares.
Highway Holdings sold $7 million of convertible preferred shares to David Lazar, which would equal about 95% of its common stock after conversion, and plans to spin off its legacy business.
Flyte Aviation signed a non-binding LOI to sell Catheter Precision's VIVO, LockeT and related life sciences assets for cash plus possible contingent payments.